- feeds
- popular
- recent
- reader
- about
- story
- technologies
- what is rss
- connect
- dmca
- contact
- Feed Preview
Statin therapy may help HFpEF patients lower their risk of death, heart attack or stroke
All participants were free of ASCVD and had no history of statin use at the start of the study.
https://cardiovascularbusiness.com/topics/clinical/heart-failure/statin-therapy-hfpef-heart-failure
FDA approves Medtronic’s next-generation TAVR system with new frame design
The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more ...
SPECT still has an important role to play in nuclear cardiology
"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.
Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke
The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.
TAVR is often more cost-effective than SAVR—but not always
Average lengths of stay and common complications are just some of the factors care teams should consider when evaluating the costs of aortic valve replacement.
Hospital accused of implanting experimental heart valve in young patient without proper consent
Members of Congress are now asking the FDA to investigate a parent's claim that her 14-year-old son was treated with an experimental heart valve without proper consent. The valve eventually faile...
Report: Johnson & Johnson once again considering deal to acquire Shockwave Medical
Healthcare giants Boston Scientific, Johnson & Johnson and Medtronic were all reportedly interested in acquiring Shockwave Medical in 2023. Now, new rumors suggest a deal could be finalized withi...
FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
New data registry will track how AI-powered plaque assessments impact cardiologist decisions
HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.
Microplastics in carotid plaques increase risk of adverse cardiovascular outcomes
Polyethylene was present in 58.4% of patients, and polyvinyl chloride was present in 12.1%. The presence of either one was associated with an increased risk of heart attack, stroke or death.
Heart attacks after TAVR: New AMI data ‘reassuring’ at first glance, but questions remain
Hoping to gain a better understanding of how TAVR may impact a patient’s long-term cardiovascular health, researchers explored data from more than 200,000 patients and shared their findings in ...
Cardiologists received $1.3B in industry payments over 10-year period, No. 3 among all healthcare specialties
Only orthopedic surgeons and neurologists/psychiatrists received more industry payments from 2013 to 2022 than cardiologists. Also, the two prescription medications associated with the most physi...
Biosense Webster takes key step toward FDA approval for Varipulse PFA system
The company already received CE mark approval for its new PFA offering and hopes it will soon be approved for sale in the United States.
Donor hearts more likely to be accepted when the transplant candidate is female or white
"This finding suggests racial and gender bias as a potential contributor to the organ acceptance decision-making process," researchers wrote in JAMA.
Cardiologists see value in AI-based plaque assessments
Cardiologists were asked to develop a care strategy for CAD patients before and after using an FDA-approved AI tool to evaluate CT results. In two out of three cases, the AI influenced cardiologi...
New study provides ‘substantial evidence’ paclitaxel-coated devices are safe when treating lower-limb PAD
Research published in 2018 caused many in the cardiology community to shy away from using these devices, and the FDA even issued warnings about their safety. However, new data suggest paclitaxel...
New risk score helps cardiologists predict when TAVR patients may require dialysis
Patients who need renal replacement therapy after TAVR are much less likely to survive. Researchers hope their new risk score can help care teams prepare ahead of time for this rare, but potenti...
Moderate prosthesis-patient mismatch after SAVR linked to worse long-term outcomes
The long-term impact of moderate PPM remains unclear. To learn more, researchers explored dozens of different studies from over the years, sharing their work in the Journal of the American Heart...
Risk of heart disease skyrockets when young, middle-aged women regularly drink alcohol
"I wasn’t expecting these results among women in this lower age group, because we usually see increased risk for heart disease among older women," one cardiologist said. "It was definitely surp...
FDA approves Abbott’s TriClip TEER device for tricuspid regurgitation
Less than two months after an FDA advisory panel voted in favor of approval, the transcatheter edge-to-edge repair system can now be sold and marketed in the United States.
FDA approves new AI model for detecting signs of heart failure with a stethoscope
Eko Health worked closely with Mayo Clinic to develop and evaluate its latest AI offering. “Importantly, since a stethoscope is small and portable, this technology can be used in urban and rem...
Cardiology groups want to ‘transform the future of cardiovascular medicine’ with new medical board
Leaders from the American Heart Association, American College of Cardiology, Heart Failure Society of America, Heart Rhythm Society and Society for Cardiovascular Angiography & Interventions...
PaceMate hits 100,000th patient transmission milestone with cutting-edge ambulatory remote monitoring platform
PaceMate, a market-leading cardiac remote monitoring and cardiac data management platform, announced today the completion of its 100,000th ambulatory patient transmission managed through PaceMat...
VR before TAVR predicts paravalvular leak in high-risk patients
Performing virtual reality simulations before TAVR may help cardiologists anticipate when PVL could be an issue in patients with severe BAV AS.
Novo Nordisk to acquire biotech company working on new heart failure drug for $1.1B
Cardior Pharmaceuticals in Germany has been developing a new compound it says can “halt and partially reverse cellular pathology” in heart failure patients.
On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms
Researchers explored data from nearly 70,000 patients, sharing their findings in the American Journal of Cardiology.
Doctors form new coalition focused on reducing private equity’s role in cardiology, other healthcare specialties
More than 5,000 U.S. physicians joined forces to launch the new group. They say they are focused on limiting private equity's involvement and influence in healthcare.
Cardiologists share historic research that led to FDA’s long-awaited approval of coronary DCB
When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched ...
New research underway on credit card-sized heart monitor that synthesizes 12-lead ECGs
The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.
Peripheral artery disease is out of control in many rural, low income communities
Peripheral artery disease (PAD) leads to more than 400 leg amputations per day in the U.S. Kumar Madassery, MD, discussed the importance of increasing awareness and reaching patients before it is...
Too much niacin? Excess vitamin B3 may increase risk of heart attack, stroke
Nutritionists view niacin, also known as vitamin B3, as a fundamental part of any diet. Consuming too much, however, could potentially be bad for the heart.
Cardiologist shares his long journey from Libya to United States
Abdel Almanfi, MD, went through years of training in Libya, but then he had to start over once he landed in the United States.
Edwards, Abbott share updated TAVR data at CRT 2024
Some of the world’s biggest names in interventional cardiology and structural heart disease gathered in Washington, D.C., for the four-day event.
Diabetes increases risk of death, complications when patients undergo CABG or PCI for left main disease
Researchers also found that CABG and PCI were each associated with their own advantages and disadvantages, highlighting the importance of shared decision-making.
FDA grants new resorbable scaffold for CLTI its breakthrough device designation
Biotronik's Freesolve technology, which gained CE mark approval in February, is designed to maximize blood flow and minimize the post-implantation risks of stent thrombosis and target lesion rev...
Incidental breast calcifications on mammograms linked to much higher risk of cardiovascular disease
These findings may say a lot more about a patient's long-term health than clinicians realized.
Intermittent fasting may increase risk of death from heart attack, stroke
Time-restricted eating is popular in the United States, but new research suggests it may do more harm than good if taken to certain extremes.
ACC.24 to make the business side of cardiology a priority
While the American College of Cardiology's annual meeting has historically had a more clinical focus, presentations at this year's conference in Atlanta will spend much more time looking at the b...
Cardiologists are first in world to remove unstable Watchman devices with FDA-cleared retrieval system
A team of specialists in Houston made history, using the new-look device to treat three patients over the age of 80. The group shared its experience in JACC: Clinical Electrophysiology.
Interventional techniques can help limit amputations among CLI patients
Kumar Madassery, MD, detailed some of the techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation.
New DCD heart transplant technique could reduce risk of serious injury
This new approach to transplanting deceased after circulatory death (DCD) hearts may offer significant benefits.
FDA approves new hypertension drug months after Idorsia reacquired rights for $343M
Aprocitentan, sold under the brand name Tryvio, is approved for patients with high blood pressure who are already taking other antihypertensive drugs.
‘Highly effective’: COVID-19 vaccines reduced risk of heart failure, other cardiovascular complications after infection
Researchers explored data from more than 20 million adults for the new study, tracking both short- and long-term outcomes.
FDA announces new recall impacting more than 66,000 Impella heart pumps after 49 deaths
More than 100 patients have been seriously injured as a result of a significant safety concern. The Impella devices can still be used, according to the recall, if customers refer to Abiomed's new...
A possible remedy for cardiology’s staffing shortages: heart failure internists
Internal medicine physicians spend a lot of time working with heart failure patients. A new commentary in JACC: Heart Failure explored the potential impact of providing IM trainees with special t...
FDA grants new implant for BTK arterial disease its breakthrough device designation
Elixir Medical's DynamX BTK System is an implantable device that supports BTK vessels after PCI or other interventions.
Going green in the cath lab makes economic sense
New research explored the potential savings of turning off angiography systems at night and on weekends.
Medicare will now cover weight loss drug semaglutide if taken for heart benefits
The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.
FDA announces recall of more than 300,000 catheter kits after 10 injuries, 1 death
This recall is due to reports of “increased resistance” when using the devices. There have been 194 customer complaints about the issue so far.
Cardiology, radiology groups urge insurance provider to rethink imaging policy
SCAI and four other major healthcare organizations signed a joint letter in support of intravascular ultrasound.
American Heart Association thinks pharmacists can play a bigger role in AFib care
Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for AFib patients?
Motivation helps heart patients stay active
Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically active.
PHOTO GALLERY: Highlights from ACC.24 in Atlanta
ACC.24, the American College of Cardiology's annual meeting in Atlanta, featured the latest in cardiovascular research and technologies. Representatives from Cardiovascular Business were there in...
New cardiac imaging strategy could reduce ICA, PCI rates
Radiologists with Massachusetts General Hospital found that the selective use of cardiac CT and AI-based CAD evaluations could make a significant impact on patient care.
Anemia may help explain why women are more likely to die during heart bypass surgery
Finding new ways to avoid intraoperative anemia could go a long way toward improving outcomes for female CABG patients. The full analysis, based on more than 1.4 million patients, was published ...
FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
The new gene therapy candidate is now one step closer to being approved by the FDA.
New ACC President Cathie Biga wants to improve quality reporting in cardiology
Biga, who originally trained as a nurse, specializes in the business side of cardiology. She also emphasized the increasing importance of AI and other new technologies.
Boston Scientific recalls premixed embolic agent after two deaths
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower...
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview.
Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.
2 out of 5 AFib patients develop heart failure later in life
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat.
Bayer subsidiary granted FDA’s fast track designation for new congestive heart failure treatment
AskBio, acquired by Bayer for more than $2 billion in 2020, is enrolling patients for a new clinical trial focused on the therapy's effectiveness in adult patients with non-ischemic cardiomyopa...
Cardiologist salary update: Compensation jumps to $525K per year, No. 3 among all specialties
In addition, cardiologists average an additional $75,000 per year in incentive-based bonuses. That number is only higher for two other specialties.
Keto diet ‘does not fulfill the criteria of a healthy diet,’ could be harmful for heart patients
The popular high-fat, low-carb diet is associated with multiple short-term benefits, but they appear to diminish over time.
Cardiologist killed in apparent murder-suicide
Marsha Certain, MD, FACC, was an interventional cardiologist in Brunswick, Georgia, for nearly 40 years.
Cardiologist loses medical license for allegedly ‘fondling and groping’ multiple patients
“The alleged conduct of this physician is so egregious, only the permanent revocation of his license could adequately protect the public from the risks posed by his return to practice," one off...
Sex, energy drinks and vaccines among the many topics planned for preventive cardiology conference
The three-day event will include sessions about sexual activity among heart patients, depression, energy drinks, stimulants, vaccines and more. The festivities begin Thursday, April 25, in Greece...
TAVR or SAVR? ChatGPT could help cardiologists decide
Researchers asked ChatGPT to make treatment decisions for patients with severe aortic stenosis, comparing its answers to the recommendations of a full heart team.
AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required
Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.
Diabetic cardiomyopathy treatment shows promise in ARISE-HF
James Januzzi Jr., MD, said the treatment's overall impact was neutral, but he and his team saw "a very clear and encouraging signal."
Q&A: Cleveland Clinic’s Lars Svensson previews AATS annual meeting
Svensson, a prominent voice in cardiothoracic surgery, said he has seen a rise in enthusiasm ahead of this year's meeting.
‘Your heart belongs here’: Improved device, economics help cardiologists keep more patients close to home
Munster, Indiana, is a thriving suburb 30 miles south of the heart of Chicago. It’s a place where the locals like to stay local, especially when it comes to healthcare. Patients in the area oft...
TAVR, SAVR linked to similar QOL improvements for intermediate-risk patients after five years
TAVR was initially associated with greater benefits than surgery, but that difference faded by the end of the first year.
New Jersey cardiologist faces up to 10 years in prison for $1.9M fraud scheme
The doctor, 76, admitted to billing multiple insurance providers for office visits that never happened at all.
FDA announces new recall of Abbott’s HeartMate LVADs after 14 deaths
The issue at the center of this recall, which includes both the HeartMate II and HeartMate 3 LVAD, is the gradual buildup of biological materials. This can impact the device's performance, creati...
GE Healthcare launching new AI software for handheld ultrasound system
The company's new AI offering, a product of its 2023 acquisition of Caption Health, will make its debut at ACC.24 in Atlanta.
ACC.24: TAVR linked to lower 1-year mortality, stroke rates than SAVR in low-risk patients
TAVR is noninferior to SAVR when treating low-risk patients, according to new data presented at ACC.24. In fact, it is associated with multiple benefits over surgery.
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
The recall is due to ongoing concerns about the devices breaking. Three patients have been injured as a result of this issue.
Cardiologist-approved VR for interventional procedures headed to ACC.24
San Francisco-based Osso VR and the American College of Cardiology have collaborated on advanced LAAO simulations. The two groups first started working together back in 2022.
TPVR with self-expanding Harmony valve associated with ‘excellent’ real-world outcomes
Transcatheter pulmonary valve replacement is still linked to certain risks, researchers noted, but new data confirm it is a safe, effective treatment option for patients with severe PR.
Johnson & Johnson to acquire Shockwave Medical for $13.1B
The rumors, it seems, were true. Once the deal is finalized, Shockwave Medical will operate as a business unit within Johnson & Johnson MedTech.
Day 1 at ACC.24: Late-breakers examine potential new heart attack, heart failure treatments
ACC.24 in Atlanta began Saturday, April 6, with a series of late-breaking clinical trials exploring brand new treatment strategies.
Weight loss drug semaglutide benefits obese patients presenting with HFpEF, type 2 diabetes
The new research, based on data from more than 600 patients, was presented at ACC.24 in Atlanta and published in the New England Journal of Medicine. Semaglutide is sold by Novo Nordisk under th...
ACC.24: Self-expanding Evolut valves offer superior performance for TAVR patients with small annuli
The SMART trial included one-year data from TAVR patients randomized to receive either a self-expanding Evolut valve or a balloon-expandable Sapien 3 valve. All patients presented with symptomati...
ACC.24: Impella CP boosts survival for patients with STEMI-related cardiogenic shock
“This is the first time in a very long time that we have a positive study for managing cardiogenic shock,” one cardiologist said.
Cardiologist moves to Mississippi to fight back against PAD and limit amputations
Interventional cardiologist Foluso Fakorede, MD, opened a practice in rural Mississippi, the epicenter of the PAD and CLI epidemic, to try and reverse the glaring health disparities in that regio...
Medicare drops AUC requirement for advanced imaging, ASNC celebrates
"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.
ACC.24: New data suggest early PCI limits risks of vulnerable plaques—cardiologists are skeptical
The PREVENT study, presented at ACC.24, examined more than 1,600 patients with high-risk plaques treated with either preventive PCI or medical therapy alone. Outcomes were much better for the PCI...
Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF
Gregg Stone, MD, explains the details of the late-breaking RELIEVE-HF trial at ACC.24, where an inter-atrial shunt improved symptoms in HFrEF, but not in HFpEF patients.
Watchdog group calls out risks associated with private equity in cardiology, other specialties
U.S. Senator Elizabeth Warren, an outspoken critic of private equity's influence, praised the group's efforts. "Together, we’re taking on this trillion-dollar, behemoth industry that’s hurtin...
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
The anticoagulant was originally developed for patients with end-stage renal disease and atrial fibrillation.
ACC in-person attendance surpasses pre-COVID numbers for first time
"We were thrilled with the meeting and the attendance," ACC President Cathie Biga, RN, told Cardiovascular Business.
First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required
An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFRCT alone. This approach is safe and feasib...
First look at data on Biosense Webster Dual Energy THERMOCO...SF platform for atrial fibrillation presented at EHRA Congress
The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is the first dual energy pulsed field (PF) ablation / radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index.
TAVR, SAVR both linked to low reintervention rates after five years
While most TAVR-related reinterventions occurred in the first year after treatment, most SAVR-related reinterventions occurred in years two through five. The team's full analysis is available in ...
Cardiologist highlights key takeaways from SMART trial, which looked at TAVR in small annulus patients
Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli.
FDA grants new imaging tool for CTO interventions its breakthrough device designation
The new device delivers real-time OCT visualization during revascularization procedures.
Critics call out ‘woefully inadequate’ CMS proposal for inpatient Medicare payments
CMS has issued its proposed rule for the 2025 Medicare hospital inpatient prospective payment system, suggesting a payment increase of 2.6%. According to the American Hospital Association, this u...
The growing shortage or general cardiologists and recruiting crisis in rural America
There is a rapidly growing shortage in general cardiologists and for positions in rural areas, numerous healthcare system recruiters set up at the ACC reported.
Most physicians think private equity is bad for healthcare
Just 10.5% of U.S. physicians said they view private equity ownership in healthcare in a positive light.